Amendment 2025-0752s to SB119 (2025)

Relative to Medicaid pharmaceutical services.


Revision: March 5, 2025, 3:30 p.m.

Sen. Rosenwald, Dist 13

March 5, 2025

2025-0752s

05/08

 

 

Floor Amendment to SB 119-FN

 

Amend the title of the bill by replacing it with the following:

 

AN ACT relative to Medicaid pharmaceutical services and repealing prospective termination of the New Hampshire granite advantage health care program if the federal match rate falls below a specified amount.

 

Amend the bill by replacing all after section 3 with the following:

 

4  Repeal; New Hampshire Granite Advantage Health Care Program.  2014, 3:10, I, as amended by 2016, 13:13 and 2018, 342:12, relative to termination of the New Hampshire granite advantage health care program if the federal match rate falls below a specified amount, is repealed.

5  Effective Date.  

I.  Section 4 of this act shall take effect upon its passage.

II.  The remainder of this act shall take effect July 1, 2025.

2025-0752s

AMENDED ANALYSIS

 

This bill:

 

I.  Directs pharmacists to dispense brand name drugs to Medicaid beneficiaries when the brand name drug is on the department of health and human services preferred drug list.

 

II.  Directs the department of health and human services to develop a standing order for certain Medicaid-covered, over-the-counter medications, medical supplies, and laboratory tests when deemed medically necessary and cost effective by the department.

 

III.  Repeals the requirement that expanded Medicaid, also known as the New Hampshire granite advantage health care program, be terminated if the federal match rate falls below 90 percent.